Zeenat Safdar, MD
Enriched profileProfessor of Medicine, Houston Methodist Academic Institute (Ashley Lain Barras Distinguished Chair in Pulmonology, Charles W. Duncan Jr. Department of Medicine); Medical Director, Houston Methodist Lung Center; Director, Clinical Research and Pulmonary Hypertension Program · Houston Methodist Hospital
Zeenat Safdar is Professor of Medicine, Houston Methodist Academic Institute (Ashley Lain Barras Distinguished Chair in Pulmonology, Charles W. Duncan Jr. Department of Medicine); Medical Director, Houston Methodist Lung Center; Director, Clinical Research and Pulmonary Hypertension Program at Houston Methodist Hospital. OpenAlex indexes 137 publications with 4,520 citations (h-index 27); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Zeenat Safdar, MD, is Professor of Medicine, Houston Methodist Academic Institute (Ashley Lain Barras Distinguished Chair in Pulmonology, Charles W. Duncan Jr. Department of Medicine) at Houston Methodist Hospital / Houston Methodist Academic Institute, Houston, TX. The public record shows 137 publications with 4,520 citations (h-index 27), centered on Respiratory. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 24 companies, 1 NIH-funded awards (2010–2014).
- Most recent indexed publication: 2024 · Case reports in pulmonology
- Top research focus: Respiratory
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 24 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Sponsor: Duke University
- Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
Sponsor: Baylor College of Medicine
Industry payments
Updated 27 Aug 2026
24 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Actelion Pharmaceuticals US, Inc.Program year20259 payments$13,990openpaymentsdata.cms.gov ↗
- United Therapeutics CorporationProgram year202525 payments$10,802openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202510 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
37.1%Endothelin Receptor Antagonist18.8%Opsumit80%Letairis10%Ambrisentan10%Part D<11 patientsLoop diuretic4.5%Furosemide100%Part D≥43 patientsBlood & clotting
14.1%Prostacycline Vasodilator6.5%Orenitram Er68%Tyvaso Dpi32%Part D<11 patientsProstacyclin Receptor Agonist6.2%Uptravi100%Part D≥19 patientsRespiratory
12.3%Corticosteroid7%Breo Ellipta48%Trelegy Ellipta34%Symbicort11%Fluticasone Propionate8%Part D<11 patientsLeukotriene Receptor Antagonist4.5%Montelukast Sodium100%Part D≥40 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2010–2014 per NIH RePORTER. The latest:
- Effect of Spironolactone of Collagen Synthesis in Pulmonary Arterial Hypertension
Baylor College of Medicine
FY2014$141,750K23HL093214 - Effect of Spironolactone of Collagen Synthesis in Pulmonary Arterial Hypertension
Baylor College of Medicine
FY2013$141,750K23HL093214 - Effect of Spironolactone of Collagen Synthesis in Pulmonary Arterial Hypertension
Baylor College of Medicine
FY2012$141,750K23HL093214
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Acute Myocardial Infarction in the Setting of Pulmonary Hypertension due to a Patent Foramen Ovale and Paradoxical Embolism.
Case reports in pulmonology
Case Report2024 - Spironolactone in pulmonary arterial hypertension: results of a cross-over study.
Pulmonary circulation
Article2020 - Transition from selexipag to oral treprostinil in a patient with pulmonary arterial hypertension.
Pulmonary circulation
Case Report2020 - Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol.
Case reports in pulmonology
Case Report2020
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/houston-methodist_our-professor-of-medicine-dr-zeenat-safdar-activity-7179115591771852802-pgBK
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - LinkedIn
LinkedIn profile: Zeenat Safdar, MD, MS, ATSF, Weill Cornell Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
- MD
SUNY Downstate Health Science Center (Brooklyn, NY); fellowship, Columbia University College of Physicians & Surgeons at St. Luke's-Roosevelt Hospital Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hilarispublisher.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →directory.curehht.org ↗
- Board certified
Critical Care Medicine (also practices Pulmonary Disease and Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
Editorial & leadership roles
journal and society appointments- Chair
Young Council, Pulmonary Vascular Research Institute (PVRI)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗ - Pulmonology Chair
Pulmonary Hypertension Association (PHA) Online University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗ - National Chair
PHA on the Road program (Pulmonary Hypertension Association)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
Awards & honors
honors on the public record- NIH K23 Career Development Award
for research on the renin-angiotensin-aldosterone system in pulmonary hypertension
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
- Adjunct Associate Professor of Medicine
Baylor College of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.houstonmethodist.org ↗
Media & interviews
press, podcasts and appearances- Faculty speaker
IMPACT PH Lecture Series (pah.tv)
- Live speaker
Houston Methodist Webinar Series on COVID-19 (video)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newswise.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.